VILAS Ventures Backs CND Life Sciences with $13.5Million Series A3
May 15, 2025
VILAS Ventures, a healthcare-focused investment firm, announced its participation in the $13.5Million Series A3 equity financing for CND Life Sciences, a pioneering diagnostics company developing innovative